Results 91 to 100 of about 4,267 (203)

Inter‐Nanoparticle FRET for Biosensing: Photophysics Versus Size

open access: yesAngewandte Chemie International Edition, Volume 64, Issue 39, September 22, 2025.
Förster resonance energy transfer (FRET) systems with luminescent nanoparticles (NPs) as donors and acceptors (inter‐NP FRET) combine unique photophysical properties with large sizes. This review discusses the influence of NP type, architecture, surface chemistry, and optical properties on FRET and the pros and cons of inter‐NP FRET for bioanalytical ...
Eduard Madirov   +3 more
wiley   +1 more source

Prevalence and impact of additional CHIP mutations in JAK2V617F‐positive ischaemic cerebrovascular patients

open access: yesBritish Journal of Haematology, Volume 207, Issue 3, Page 1029-1037, September 2025.
Summary The JAK2V617F mutation is associated with increased cardiovascular risk, including ischaemic stroke. This study investigates the prevalence of additional mutations in ischaemic cerebrovascular patients with and without JAK2V617F to better understand the mechanisms contributing to thrombotic risk.
Marie Hvelplund Kristiansen   +6 more
wiley   +1 more source

HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.

open access: yesPLoS ONE, 2013
Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length soluble uPAR (suPAR) and cleaved (c-suPAR) form that maintain ability to bind to integrins and other receptors, thus triggering and modulating cell ...
Manuela Nebuloni   +8 more
doaj   +1 more source

Admission diagnosis for each suPAR tertile.

open access: yes, 2017
Admission diagnosis for each suPAR tertile.
Takahide Ito (495210)   +7 more
core   +1 more source

Table_1_Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.docx

open access: yes, 2021
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases.
Jesper Eugen-Olsen (39433)   +2 more
core   +1 more source

Host Response Biomarker in Sepsis: suPAR Detection

open access: yes, 2014
Recent studies of our group have shown that suPAR may complement APACHE II score for risk assessment in sepsis. suPAR may be measured in serum of patients by an enzyme immunosorbent assay developed by Virogates (suPARnostic™). Production of suPAR from circulating neutrophils and monocytes may be assessed after isolation of neutrophils and monocytes and
Giamarellos-Bourboulis, Evangelos J.   +1 more
openaire   +3 more sources

SuPAR and PAI-1 in critically ill, mechanically ventilated patients

open access: yes, 2013
PURPOSE:SuPAR (soluble urokinase plasminogen activator receptor) and PAI-1 (plasminogen activator inhibitor 1) are active in the coagulation-fibrinolysis pathway. Both have been suggested as biomarkers for disease severity.
Yang, Runkuan   +7 more
core   +1 more source

suPAR: The unspecific marker for disease presence, severity and prognosis

open access: yesInternational Journal of Antimicrobial Agents, 2015
Investigation of biomarkers that can promptly predict unfavourable outcome of critically illness is an emerging necessity taking into consideration the need for early intervention, the shortage of available beds in intensive care units and the considerable cost of hospitalisation.
Eugen-Olsen, J.   +1 more
openaire   +3 more sources

The diagnostic value of supar in newborns with neonatal sepsis diagnosis

open access: yes, 2023
Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Ana Bilim DalıÖZET Yenidoğan dönemi hayatın ilk 28 günüdür. Enfeksiyon etkeni bir mikroorganizma tarafından yenidoğanın herhangi bir dokusununun istilasına karşı, yenidoğanın inflamatuar süreçleri içeren ...
Sertoğlu, Fatıma Sümeyye
core  

Rola suPAR w chorobach nerek

open access: yes, 2017
Chronic kidney disease (CKD) is unquestionably a problem of social significance because it affects about 10% of the population. There is a search for biomarkers which could help select persons out of such a large group of patients with a high risk of ...
Grzeszczak, Władysław   +3 more
core  

Home - About - Disclaimer - Privacy